GlassScriptPhysician profile
Alexander Upfill-Brown
NPI 1659830529
$17,080.10
in general payments reported to CMS, 2019-2025
15 companies · $7,910 in 2025
The $7,910 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,174 · 2022: $756 · 2023: $2,970 · 2024: $1,269 · 2025: $7,910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,346 · Food and Beverage: $4,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,345.92 |
| Food and Beverage | $4,804.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $9,603.27 | 2021-2025 | Excelsius Gps, Xlif, Ankle Fracture System |
| Alphatec Spine, INC | $1,508.60 | 2025 | Other - Miscellaneous, Lif, Invictus Open |
| Stryker Corporation | $1,161.15 | 2022-2025 | T2 Alpha, Pangea, Gamma |
| Orthofix Medical, INC. | $1,067.02 | 2023 | Northstar, Mariner, Spinal-Stim |
| Zimmer Biomet Holdings, INC. | $1,017.42 | 2021-2025 | |
| Synthes Gmbh | $832.22 | 2025 | |
| Nuvasive, INC. | $668.60 | 2021-2023 | Xlif, Maxcess, Tlif |
| Acuity Surgical Devices, LLC | $452.31 | 2025 | |
| Cerapedics INC. | $244.22 | 2021-2024 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $242.23 | 2022-2023 | |
| Highridge Medical LLC | $94.98 | 2025 | Vital |
| Suvon Surgical LLC | $75.69 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $57.94 | 2023 | Exparel, Zilretta, Iovera |
| Zimvie INC. | $40.68 | 2023 | |
| Acera Surgical, INC. | $13.77 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Upfill-Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.